Detection of isolated ipsilateral regional lymph node recurrences by F18-fluorodeoxyglucose positron emission tomography-CT in follow-up of postoperative breast cancer patients

Breast Cancer Research and Treatment

Volumn 130, Issue 1, 2011, Pages 267-272

  Ohsumi, Shozo ^a   Inoue, Takeshi ^a   Kiyoto, Sachiko ^a   Hara, Fumikata ^a   Takahashi, Mina ^a   Takabatake, Daisuke ^a   Takashima, Seiki ^a   Aogi, Kenjiro ^a   Takashima, Shigemitsu ^a  

^a NATIONAL HOSPITAL ORGANIZATION   (Japan)

Author keywords

Breast cancer; Follow up; Lymph node recurrences; PET; PET CT

Indexed keywords

CA 15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; ASYMPTOMATIC DISEASE; AXILLARY LYMPH NODE; BILE DUCT CARCINOMA; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RECURRENCE; CANCER STAGING; COLON CANCER; CONTRALATERAL BREAST CANCER; CROSS-SECTIONAL STUDY; DIAGNOSTIC ERROR; EARLY CANCER; EARLY DIAGNOSIS; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HUMAN; INCIDENTAL FINDING; INFRACLAVICULAR LYMPH NODE; LUNG CANCER; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; PALPATION; PANCREAS CANCER; PARASTERNAL LYMPH NODE; PARTIAL MASTECTOMY; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PREOPERATIVE CHEMOTHERAPY; PRIMARY TUMOR; PRIORITY JOURNAL; RECTUM CANCER; SENTINEL LYMPH NODE BIOPSY; STOMACH CANCER; SUPRACLAVICULAR LYMPH NODE; THORAX RADIOGRAPHY; THYROID CANCER; TUMOR VOLUME; ULTRASOUND; WHOLE BODY CT;

ADULT; AGED; AGED, 80 AND OVER; ASYMPTOMATIC DISEASES; BREAST NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; POSTOPERATIVE PERIOD; YOUNG ADULT;

EID: 82455167996     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1561-8     Document Type: Article

References (18)

1. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials. Lancet 365(9472):1687-1717
2. Greenberg PA, Hortobagyi GN, Smith TL, Ziegler LD, Frye DK, Buzdar AU (1996) Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. J Clin Oncol 14(8):2197-2205 (Pubitemid 26264869)
3. The GIVIO Investigators (1994) Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. JAMA 271(20):1587-1592
4. Rosselli Del Turco M, Palli D, Cariddi A, Ciatto S, Pacini P, Distante V (1994) Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up. JAMA 271(20):1593-1597 (Pubitemid 24155619)
5. Khatcheressian JL, Wolff AC, Smith TJ, Grunfeld E, Muss HB, Vogel VG, Halberg F, Somerfield MR, Davidson NE (2006) American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol 24(31):5091-5097 (Pubitemid 46631413)
6. Veronesi U, Arnone P, Veronesi P, Galimberti V, Luini A, Rotmensz N, Botteri E, Ivaldi GB, Leonardi MC, Viale G, Sagona A, Paganelli G, Panzeri R, Orecchia R (2008) The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large series. Ann Oncol 19(9):1553-1560
7. Brito RA, Valero V, Buzdar AU, Booser DJ, Ames F, Strom E, Ross M, Theriault RL, Frye D, Kau S-W, Asmar L, McNeese M, Singletary SE, Hortobagyi GN (2001) Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: the University of Texas M. D. Anderson Cancer Center Experience. J Clin Oncol 19(3):628-633 (Pubitemid 32119077)
8. Olivotto IA, Chua B, Allan SJ, Speers CH, Chia S, Ragaz J (2003) Long-term survival of patients with supraclavicular metastases at diagnosis of breast cancer. J Clin Oncol 21(5):851-854 (Pubitemid 46606445)
9. Recht A, Edge SB, Solin LJ, Robinson DS, Estabrook A, Fine RE, Fleming GF, Formenti S, Hudis C, Kirshner JJ, Krause DA, Kuske RR, Langer AS, Sledge GW Jr, Whelan TJ, Pfister DG (2001) Postmastectomy radiotherapy: clinical practice guidelines of the American society of clinical oncology. J Clin Oncol 19(5):1539-1569 (Pubitemid 32203717)
10. Sobin L, Gospodarowicz M, Wittekind C (2010) Classification of malignant tumours, 7th edn. Wiley-Blackwell, Oxford
11. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) Cancer staging manual, 7th edn. Springer, New York
12. Hodgson NC, Gulenchyn KY (2008) Is there a role for positron emission tomography in breast cancer staging? J Clin Oncol 26(5):712-720 (Pubitemid 351264383)
13. Escalona S, Blasco JA, Reza MM, Andradas E, Gomez N (2010) A systematic review of FDG-PET in breast cancer. Med Oncol 27(1):114-129
14. Isasi CR, Moadel RM, Blaufox MD (2005) A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases. Breast Cancer Res Treat 90(2):105-112 (Pubitemid 40568893)
15. Piperkova E, Raphael B, Altinyay ME, Castellon I, Libes R, Sandella N, Heiba S, Abdel-Dayem H (2007) Impact of PET/CT in comparison with same day contrast enhanced CT in breast cancer management. Clin Nucl Med 32(6):429-434 (Pubitemid 46791460)
16. Schmidt GP, Baur-Melnyk A, Haug A, Heinemann V, Bauerfeind I, Reiser MF, Schoenberg SO (2008) Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT. Eur J Radiol 65(1):47-58
17. Antoch G, Vogt FM, Freudenberg LS, Nazaradeh F, Goehde SC, Barkhausen J, Dahmen G, Bockisch A, Debatin JF, Ruehm SG (2003) Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA 290(24):3199-3206 (Pubitemid 38020681)
18. Lu WL, Jansen L, Post WJ, Bonnema J, Van de Velde JC, De Bock GH (2009) Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Treat 114(3):403-412